Core decompression of the femoral head. Literature review

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Avascular necrosis (AVN) of the femoral head is a disease, characterized by the death of osteocytes and bone marrow, leading to collapse of the femoral head and dysfunction of the hip joint. There are many known risk factors for the development of this disease including trauma of the hip joint, hemoglobinopathy, alcoholism, taking corticosteroids, collagenosis, etc. Conservative treatment (drug therapy using vascular drugs, bisphosphonates, chondroprotectors, NSAIDs, physiotherapy, exercise therapy) is shown for any stage of the hip AVN, however, surgical treatment has a higher potential. The key to successful treatment is the detection of AVN at an early (pre-collapse) stage to prevent subsequent collapse by performing organ-sparing surgical interventions that reduce the rate of disease progression and allow delaying of the hip replacement. The literature describes a number of organ-preserving operations performed at an early stage of AVN. Currently, there are three main areas of surgical treatment of this disease: classical decompression of the femoral head, decompression using various types of grafts and combined treatment using various cellular technologies. This literature review is devoted to the consideration of the indications for implementation, as well as the results of treatment of patients using the above techniques.

Full Text

Restricted Access

About the authors

Mikhail A. Panin

Peoples Friendship University of Russia

ORCID iD: 0000-0003-4686-7892
SPIN-code: 5834-3500

Russian Federation, 6 Miklouho-Maclay str., Moscow, 117198

Cand. Sci. (Med.)

Nikolay V. Zagorodniy

Peoples Friendship University of Russia; N.N. Priorov National Medical Research Center

SPIN-code: 6889-8166

Russian Federation, 6 Miklouho-Maclay str., Moscow, 117198; Moscow

Dr. Sci. (Med), Professor, Corresponding Member of the Russian Academy of Medical Sciences

Medetbek D. Abakirov

Peoples Friendship University of Russia

ORCID iD: 0000-0002-5842-5904
SPIN-code: 5099-0493

Russian Federation, 6 Miklouho-Maclay str., Moscow, 117198

Cand. Sci. (Med.)

Andrey V. Boyko

Peoples Friendship University of Russia

Author for correspondence.
ORCID iD: 0000-0002-7829-2045
SPIN-code: 4543-7879

Russian Federation, 6 Miklouho-Maclay str., Moscow, 117198

postgraduate student

Danila A. Ananyin

Peoples Friendship University of Russia

ORCID iD: 0000-0003-0032-4710
SPIN-code: 1446-8368

Russian Federation, 6 Miklouho-Maclay str., Moscow, 117198

Cand. Sci. (Med.)


  1. Matveev RP, Bragina SV. Avascular necrosis of the femoral head (literature review). Human Ecology. 2018;(3):58–64. (In Russ.)
  2. Panin MA, Zagorodniy NV, Karchebnyi NN, et al. Modern view on pathogenesis of non traumatic osteonecrosis. N.N. Priorov Journal of Traumatology and Orthopedics. 2017;24(2):69–75. (In Russ.) doi: 10.17816/vto201724269-75
  3. Panin MA, Zagorodniy NV, Samokhodskaya LM, Lipov АV. The role of the genetic polymorphism of thrombocyte integrins (ITGΑ2, ITGΒ3) in the pathogenesis of non-traumatic aseptic necrosis of the femoral head. Medical news of the North Caucasus. 2020;15(1):84–87. (In Russ). doi: 10.14300/mnnc.2020.15019
  4. Rempel’ DP, Bryukhanov AV, Batrak YuM. Possibilities of methods of radiological diagnosis of damage to a symmetric joint in diagnosed aseptic necrosis of the femur. Radiologiya — Praktika. 2013;(6):24–32. (In Russ.)
  5. Martí-Carvajal AJ, Solà I, Agreda-Pérez LH. Treatment for avascular necrosis of bone in people with sickle cell disease. Cochrane Database Syst Rev. 2009;(3):CD004344. doi: 10.1002/14651858.CD004344.pub3
  6. Kachanov DA, Usov SA, Vostrilov IM, et al. Treatment options for aseptic necrosis of femoral head. Mezhdunarodnyi nauchno-issledovatel’skii zhurnal. 2019;(12):201–203. (In Russ.). doi: 10.23670/IRJ.2019.90.12.042
  7. Zorya VI, Gur’ev VV, Sklyanchuk ED. Rehabilitation of patients with initial coxarthrosis after revascularizing femur osteotomy. N.N. Priorov journal of traumatology and orthopedics. 2010;17(2):30–33. (In Russ.). doi: 10.17816/vto201017230-33
  8. Shannon BD, Trousdale RT. Femoral osteotomies for avascular necrosis of the femoral head. Clin Orthop Relat Res. 2004;(418):34–40. doi: 10.1097/00003086-200401000-00007
  9. De Smet AA, Dalinka MK, Alazraki NP, et al. American College of Radiology ACR Appropriateness Criteria®. Avascular necrosis of the hip. Reston, VA: American College of Radiology (ACR); 2005.
  10. Ficat RP, Arlet J. Functional investigation of bone under normal conditions, ischemia and necrosis of bone. Hungerford DC, editor. Baltimore: Williams & Wilkins; 1980.
  11. Arlet J, Ficat P, Lartigue G. Mode of onset of primary osteonecrosis of the femoral head. (Stage I. Uncomplicated). Study of 20 cases histologically verified by punch biopsy. Rev Rhum Mal Osteoartic. 1968;35(5):239–249. (In French)
  12. Arlet J, Ficat P, Lartigue G, Tran MA. Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis. Rev Rhum Mal Osteoartic. 1972;39(11):717–723. (In French)
  13. Hungerford DS. Core decompression of the femoral head for osteonecrosis. J Bone Joint Surg Am. 1988;70(3):474–475.
  14. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77(3):459–474. doi: 10.2106/00004623-199503000-00018
  15. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;(324):169–178. doi: 10.1097/00003086-199603000-00020
  16. Wang W, Liu L, Dang X, et al. The effect of core decompression on local expression of BMP-2, PPAR-γ and bone regeneration in the steroid-induced femoral head osteonecrosis. BMC Musculoskelet Disord. 2012;13:142. doi: 10.1186/1471-2474-13-142
  17. Castro FP, Barrack RL. Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis. Am J Orthoped. 2000;29(3):187–194.
  18. Simank HG, Brocai DR, Brill C, Lukoschek M. Comparison of results of core decompression and intertrochanteric osteotomy for nontraumatic osteonecrosis of the femoral head using Cox regression and survivorship analysis. J Arthroplasty. 2001;16(6):790–794.
  19. Steinberg ME. Core decompression of the femoral head for avascular necrosis: indications and results. Can J Surg. 1995;38 Suppl 1:S18–S24.
  20. Steinberg ME, Larcom PG, Strafford B, et al. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2001;(386):71–78.
  21. Koo K., Kim R. Quontifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br. 1995;77(6):875–880.
  22. Israelite C, Nelson CL, Ziarani CF, et al. Bilateral core decompression for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2005;441:285–290.
  23. Classen T, Warwas S, Jäger M, Landgraeber S. Two-year follow-up after advanced core decompression. J Tissue Eng Regen Med. 2017;11(4):1308–1314. doi: 10.1002/term.2056
  24. Landgraeber S., Warwas S., Claßen T., Jäger M. Modifications to advanced core decompression for treatment of avascular necrosis of the femoral head. BMC Musculoskelet Disord. 2017;18:479. doi: 10.1186/s12891-017-1811-y
  25. Huang W, Gong X, Sandiford S, et al. Outcome after a new porous tantalum rod implantation for treatment of early-stage femoral head osteonecrosis. Ann Transl Med. 2019;7(18):441. doi: 10.21037/atm.2019.08.86
  26. Liu Y, Zhou S, Su X, et al. Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty. Int Orthop. 2016;40(7):1397–1407. doi: 10.1007/s00264-015-2897-1
  27. Veillette CJ, Mehdian H, Schemitsch EH, McKee MD. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88 Suppl 3:48–55. doi: 10.2106/JBJS.F.00538
  28. Bi B., Zhang S., Zhao Y. The effect of robot-navigation-assisted core decompression on early stage osteonecrosis of the femoral head. J Orthop Surg Res. 2019;14(1):375. doi: 10.1186/s13018-019-1437-x.
  29. Gangji V, Hauzeur JP. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am. 2005;87 Suppl 1(Pt 1):106–112. doi: 10.2106/JBJS.D.02662
  30. Yan ZQ, Chen YS, Li WJ, et al. Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol. 2006;9(1):3–7.
  31. Gangji V, De Maertelaer V, Hauzeur JP, et al. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005–1009. doi: 10.1016/j.bone.2011.07.032
  32. Mesfin A, Buchowski JM, Zebala LP, et al. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases. J Bone Joint Surg Am. 2013;95(17):1546–1553. doi: 10.2106/JBJS.L.01730
  33. Kim HK, Aruwajoye O, Du J, Kamiya N. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs. J Bone Joint Surg Am. 2014;96(18):1515–1524. doi: 10.2106/JBJS.M.01361
  34. Vandermeer JS, Kamiya N, Aya-ay J, et al. Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity. J Bone Joint Surg Am. 2011;93(10):905–913. doi: 10.2106/JBJS.J.00716
  35. Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone graft-ing for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;(417):84–92.
  36. Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014;22(7):455–464. doi: 10.5435/JAAOS-22-07-455
  37. Sun W, Li Z, Gao F, et al. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLoS One. 2014;9(6):e100424. doi: 10.1371/journal.pone.0100424
  38. Parsa A, Vahedi H, Goswami K, Aalirezaie A. Available findings fail to provide strong evidence of the role of bone morphogenic protein-2 in femoral head osteonecrosis. Arch Bone Jt Surg. 2020;8(1):5–10. doi: 10.22038/abjs.2019.30467.1785
  39. Carragee EJ, Chu G, Rohatgi R, et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013;95(17):1537–1545. doi: 10.2106/JBJS.L.01483
  40. Helbig L, Simank HG, Kroeber M, et al. Core decompression combined with implantation of a demineralised bone matrix for non-traumatic osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2012;132(8):1095–1103.
  41. Bakhshi H, Rasouli MR, Parvizi J. Can local erythropoietin administration enhance bone regeneration in osteonecrosis of femoral head? Med Hypotheses. 2012;79(2):154–156. doi: 10.1016/j.mehy.2012.04.021
  42. Han J, Gao F, Li Y, et al. The use of platelet-rich plasma for the treatment of osteonecrosis of the femoral head: a systematic review. Biomed Res Int. 2020;3:264–269. doi: 10.1155/2020/2642439
  43. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502–1508. doi: 10.1097/01.prs.0000138251.07040.51
  44. Rackwitz L, Eden L, Reppenhagen S, et al. Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther. 2012;3(1):7. doi: 10.1186/scrt98
  45. Kuroda Y, Asada R, So K, et al. A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. Int Orthop. 2016;40(8):1747–1754. doi: 10.1007/s00264-015-3083-1
  46. Samy AM. Management of osteonecrosis of the femoral head: a novel technique. Indian J Orthop. 2016;50(4):359–365. doi: 10.4103/0019-5413.185590
  47. Mont MA, Einhorn TA, Sponseller PD, Hungerford DS. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head. J Bone Joint Surg Br. 1998;80(1):56–62. doi: 10.1302/0301-620X.80B1.0800056
  48. Houdek MT, Wyles CC, Collins MS, et al. Stem cells combined with platelet-rich plasma effectively treat corticosteroid-induced osteonecrosis of the hip: a prospective study. Clin Orthop Relat Res. 2018;476(2):388–397. doi: 10.1007/s11999.0000000000000033
  49. Guadilla J, Fiz N, Andia I, Sánchez M. Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip. Knee Surg Sports Traumatol Arthrosc. 2012;20(2):393–398.
  50. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11–15. doi: 10.1016/j.stem.2011.06.008
  51. Baksh D, Boland GM, Tuan RS. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem. 2007;101:1109–1124. doi: 10.1002/jcb.21097
  52. Han DS, Chang HK, Kim KR, Woo SM. Consideration of bone regeneration effect of stem cells: comparison of bone regeneration between bone marrow stem cells and adipose-derived stem cells. J Craniofac Surg. 2014;25:196–201. doi: 10.1097/SCS.0000000000000378
  53. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng. 2007;13(5):947–955. doi: 10.1089/ten.2006.0271
  54. Hernigou P, Dubory A, Homma Y, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42(7):1639–1649. doi: 10.1007/s00264-018-3941-8
  55. Talathi NS, Kamath AF. Autologous stem cell implantation with core decompression for avascular necrosis of the femoral head. J Clin Orthop Trauma. 2018;9(4):349–352. doi: 10.1016/j.jcot.2018.05.014
  56. Emadedin M, Karimi S, Karimi A, et al. Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study. Cytotherapy. 2019;21(1):107–112. doi: 10.1016/j.jcyt.2018.10.005
  57. Yu X, Zhang D, Chen X, et al. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials. J Orthop Sci. 2018;23(2):356–364. doi: 10.1016/j.jos.2017.12.004
  58. Yoon BH, Lee YK, Kim KC, et al. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. Int Orthop. 2018;42(12):2737–2743. doi: 10.1007/s00264-018-3977-9

Supplementary files

There are no supplementary files to display.



Abstract - 75

PDF (Russian) - 0


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2021 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies